Tandem Diabetes Care Inc. (TNDM) Share Price

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 16.53 High: 17.11

52 Week Range

Low: 15.75 High: 53.69

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Market capMarket cap information

    $1,149 Mln

  • P/E RatioP/E Ratio information

    --

  • P/B RatioP/B Ratio information

    4.48

  • Industry P/EIndustry P/E information

    --

  • Debt to EquityDebt to Equity information

    1.8

  • ROEROE information

    -0.33 %

  • ROCEROCE information

    -13.1 %

  • Div. YieldDiv. Yield information

    0 %

  • Book ValueBook Value information

    3.98

  • EPSEPS information

    -1.45

10 Years Aggregate

CFO

$-59.18 Mln

EBITDA

$-437.40 Mln

Net Profit

$-791.81 Mln

Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Tandem Diabetes Care (TNDM)
-53.19 -12.05 -55.08 -48.85 -47.32 -25.17 -18.70
BSE Sensex
0.39 6.40 1.96 7.69 10.43 20.75 10.61
S&P Small-Cap 600#
-5.82 -5.34 -13.73 -6.30 5.30 2.98 5.53
As on 17-Apr-2025  |  #As on 26-Oct-2023
2024
2023
2022
2021
2020
2019
2018
Tandem Diabetes Care (TNDM)
21.58 -34.19 -70.14 57.32 60.51 56.99 1,484.72
S&P Small-Cap 600
7.01 13.89 -17.42 25.27 9.57 20.86 -9.70
BSE Sensex
8.10 18.74 4.44 21.99 15.75 14.38 5.87

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

Detailed View
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View All
loading...

loading...

loading...

3Y Avg -- 5Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peer

View All
Company
Price ($) Market Cap ($ Mln) P/E Ratio ROE
15.10 10,391.68 14.66 12.69
71.01 9,766.86 94.68 2.52
152.15 8,196.06 -- -25.23
277.35 10,728.90 770.42 1.2

Shareholding Pattern

Detailed Holdings
loading...
BLAHBLAH

About The Company

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi...  insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California. Address: 12400 High Bluff Drive, San Diego, CA, United States, 92130  Read more

  • President, CEO & Director

    Mr. John F. Sheridan

  • President, CEO & Director

    Mr. John F. Sheridan

  • Headquarters

    San Diego, CA

  • Website

    https://www.tandemdiabetes.com

Edit peer-selector-edit
loading...
loading...

FAQs for Tandem Diabetes Care Inc. (TNDM)

The total asset value of Tandem Diabetes Care Inc (TNDM) stood at $ 968 Mln as on 31-Dec-24

The share price of Tandem Diabetes Care Inc (TNDM) is $16.86 (NASDAQ) as of 17-Apr-2025 16:00 EDT. Tandem Diabetes Care Inc (TNDM) has given a return of -47.32% in the last 3 years.

Tandem Diabetes Care Inc (TNDM) has a market capitalisation of $ 1,149 Mln as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.

Since, TTM earnings of Tandem Diabetes Care Inc (TNDM) is negative, P/E ratio is not available.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Tandem Diabetes Care Inc (TNDM) and enter the required number of quantities and click on buy to purchase the shares of Tandem Diabetes Care Inc (TNDM).

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California. Address: 12400 High Bluff Drive, San Diego, CA, United States, 92130

The CEO & director of Mr. John F. Sheridan. is Tandem Diabetes Care Inc (TNDM), and CFO & Sr. VP is Mr. John F. Sheridan.

There is no promoter pledging in Tandem Diabetes Care Inc (TNDM).

Tandem Diabetes Care Inc. (TNDM) Ratios
Return on equity(%)
-33.3
Operating margin(%)
-10.56
Net Margin(%)
-10.21
Dividend yield(%)
--

No, TTM profit after tax of Tandem Diabetes Care Inc (TNDM) was $0 Mln.